Most shareholders can vote by calling 1-833-782-7145 PRINCETON, N.J., May 23, 2024 /PRNewswire/ -- Soligenix, Inc. (NASDAQ:SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, encourages its eligible stockholders to vote "FOR" a Reverse Stock Split. The Company and its Board of Directors believe it is important to maintain the listing of the Common Stock on The Nasdaq Capital Market ("Nasdaq"). "Failure to maintain our listing on Nasdaq and meet Nasdaq's listing requirements has the potential to detrimentally impact our ability to attract the necessary institutional support to advance the HyBryte™ Phase 3 confirmatory trial and our other pipeline clinical programs to important value inflection points necessary to secure potential partnerships and/or additional non-dilutive government funding to build shareholder value," stated Christopher J. Schaber, PhD, President and Chief Executive Officer of Soligenix. Eligible stockholders may vote by contacting the Company's proxy solicitor, Alliance Advisors, at 1-833-782-7145. Only stockholders at the close of business on the record date, April 10, 2024, will be eligible to participate. Even stockholders as of April 10, 2024 who have subsequently sold their shares are eligible and encouraged to vote. Please refer to the official proxy materials for further details on each proposal, this can be found at https://ir.soligenix.com/sec-filings. Important Information This material may be deemed to be solicitation material in respect of the Annual Meeting. In connection with the Annual Meeting, the Company filed a definitive proxy statement and a proxy card with the SEC on April 29, 2024. BEFORE MAKING ANY VOTING DECISIONS, STOCKHOLDERS ARE URGED TO READ THE DEFINITIVE PROXY STATEMENT, THE ACCOMPANYING PROXY CARD, AND ANY AMENDMENTS OR SUPPLEMENTS TO THESE DOCUMENTS, AND ANY OTHER RELEVANT DOCUMENTS FILED WITH THE SEC, BECAUSE THEY CONTAIN IMPORTANT INFORMATION ABOUT THE ANNUAL MEETING. The proxy materials have been made available to stockholders who are entitled to vote at the Annual Meeting. The Company's definitive proxy statement and any other materials filed by the Company with the SEC can be obtained free of charge at the SEC's ...